{{Rsnum
|rsid=11763760
|Gene=IGF2BP3
|Chromosome=7
|position=23440848
|Orientation=plus
|GMAF=0.1331
|Gene_s=IGF2BP3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.9 | 33.6 | 4.4
| HCB | 96.4 | 3.6 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 78.1 | 20.5 | 1.4
| ASW | 66.7 | 31.6 | 1.8
| CHB | 96.4 | 3.6 | 0.0
| CHD | 99.1 | 0.9 | 0.0
| GIH | 41.6 | 40.6 | 17.8
| LWK | 77.3 | 21.8 | 0.9
| MEX | 79.3 | 19.0 | 1.7
| MKK | 71.8 | 25.6 | 2.6
| TSI | 60.8 | 29.4 | 9.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=C
  |Pval=2E-6
  |OR=.18
  |ORtxt=[0.11-0.26] unit decrease
  |OA=1
}}

{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}